Endoscopy devices are medical devices used to examine internal organs for diagnosis of diseases. Endoscopic Hemostasis devices consists of devices employed in the management of Gastrointestinal (GI) bleeding and often acts as the first line of therapy. GlobalData uses proprietary data and analytics to provide a comprehensive report on the endoscopic hemostasis devices devices market, including market shares of different players within Taiwan. Buy the latest report here.

Smarter leaders trust GlobalData

In 2022, GlobalData’s Market Model methodology determined that the leading player in the endoscopic hemostasis devices market in Taiwan was Boston Scientific followed by Cook Medical, ERBE Elektromedizin, ConMed, Olympus, Micro-Tech Nanjing, United States Endoscopy Group, Diversatek, Medline Industries and Integra LifeSciences.

Endoscopic Hemostasis Devices are generally classified into mechanical devices (clips, ligation devices, suturing devices, stents), injection devices (injection needles), thermal devices (hemostatic probes, hemostatic forceps, heater probe, argon plasma coagulation, radiofrequency ablation, and cryotherapy) and topical devices (hemostatic spray).

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the endoscopic hemostasis devices devices market within Taiwan was expected to be over $1m in 2022.

For the latest complete market share analysis of endoscopic hemostasis devices device market in Taiwan, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.